Biodesix closes $40M stock offering

BOULDER — Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, has closed on an upsized public stock offering that grossed $40.3 million.

The offering, launched last week in order to meet the terms of a new $50 million line of credit from a health care investment firm, involved the sale of just over 35 million new shares at $1.15 each.

“The net proceeds of the offering are expected to be used for commercial expansion of sales, supporting its product pipeline, research and development and for general corporate purposes,” Biodesix said. 

The $50 million term-loan…